InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Harris Erik, Vice-Président Exécutif et Directeur Commercial. Insider active across 3 companies, notably Ultragenyx Pharmaceutical Inc.. In total, 17 filings have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €516k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 16 April 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Harris Erik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
28,895 shares0Common StockSEC:0001193125-26-164267:0
11,643 shares0Common StockSEC:0001193125-26-089282:0
21,000 shares0Common SharesSEC:0000912282-25-001286:0
16,813 shares0Common StockSEC:0000950170-25-032773:0
5,967 shares0Common StockSEC:0001714899-24-000134:0
19,400 shares0Common StockSEC:0000950170-24-026629:0
6,000 shares@ US$37.9633.7% of flowCommon StockSEC:0001209191-23-048491:0
305 shares@ US$48.202.1% of flowCommon StockSEC:0001209191-23-038885:0
4,216 shares0Common StockSEC:0001714899-23-000094:0
2,663 shares0Common StockSEC:0001209191-23-016039:0
295 shares@ US$54.780.0006% mcap3.8% of flowCommon StockSEC:0001209191-22-038774:0
2,713 shares@ US$66.620.0065% mcap39.9% of flowCommon StockSEC:0001209191-22-015830:0
6,869 shares0Common StockSEC:0001714899-22-000024:0
303 shares@ US$81.144.1% of flowCommon StockSEC:0001209191-21-060760:0
375 shares@ US$91.535.6% of flowCommon StockSEC:0001209191-21-045972:0
437 shares@ US$94.636.7% of flowCommon StockSEC:0001209191-21-042812:0
307 shares@ US$113.685.6% of flowCommon StockSEC:0001209191-21-031378:0
17 of 17 declarations
About Harris Erik
Harris Erik is Executive Vice President and Chief Commercial Officer. He has 17 filings in total, and the 17 sampled filings cover disposals for EUR 516214 between 2021-05-10 and 2026-04-20, all at Ultragenyx Pharmaceutical Inc.
